Cargando…
Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies
BACKGROUND: Recent studies indicate that microRNAs (miRNAs) are mechanistically involved in the development of various human malignancies, suggesting that they represent a promising new class of cancer biomarkers. However, previously reported methods for measuring miRNA expression consume large amou...
Autores principales: | Mattie, Michael D, Benz, Christopher C, Bowers, Jessica, Sensinger, Kelly, Wong, Linda, Scott, Gary K, Fedele, Vita, Ginzinger, David, Getts, Robert, Haqq, Chris |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1563474/ https://www.ncbi.nlm.nih.gov/pubmed/16784538 http://dx.doi.org/10.1186/1476-4598-5-24 |
Ejemplares similares
-
High-throughput intracellular biopsy of microRNAs for dissecting the temporal dynamics of cellular heterogeneity
por: Wang, Zixun, et al.
Publicado: (2020) -
Tuning Design Parameters of ICAM-1-Targeted 3DNA Nanocarriers to Optimize Pulmonary Targeting Depending on Drug Type
por: Roki, Nikša, et al.
Publicado: (2022) -
MicroRNAs as Potential Liquid Biopsy Biomarker for Patients with Castration-Resistant Prostate Cancer
por: Fernandez, Nicolas, et al.
Publicado: (2022) -
655Val and 1170Pro ERBB2 SNPs in Familial Breast Cancer Risk and BRCA1 Alterations
por: Tommasi, Stefania, et al.
Publicado: (2007) -
Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer
por: Chan, June M., et al.
Publicado: (2010)